Sector ratings Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse

Stocks

Real-time Estimate Tradegate Other stock markets 17:06:52 30/07/2026 BST			5-day change	1st Jan Change
59.22 ^EUR	-1.21%		+6.39%	-5.29%

07-23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
07-23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
ELI LILLY AND COMPANY	1,079B		A
JOHNSON & JOHNSON	640B		BBB
ABBVIE INC.	465B		AA	-
ROCHE HOLDING AG	353B		AA
NOVARTIS AG	301B		AAA
ASTRAZENECA PLC	271B		A
NOVO NORDISK A/S	228B		A
AMGEN INC.	209B		A
GILEAD SCIENCES, INC.	165B		AA
PFIZER INC.	143B		A
BRISTOL-MYERS SQUIBB COMPANY	129B		A
VERTEX PHARMACEUTICALS INCORPORATED	123B		AA
SANOFI	109B		AA
GSK PLC	106B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	70.98B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.98B		AA
BAYER AG	53.32B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.55B		AA
Average	243.03B		AA
Weighted average by Cap.			AA